市建局觀塘第四及第五發展區獲最少9份意向書
市建局九龍觀塘市中心第四及第五發展區今日(7日)截收發展意向書。現場所見,項目最少獲得9份意向書,包括鷹君(00041.HK)及中國海外(00688.HK)入標。
觀塘市中心項目爲市建局歷來單一最大規模重建項目,是次推出的是最後一個發展區,佔地約27.5萬平方尺,總樓面面積上限達216萬平方尺,將興建一個地標式綜合政府設施及商業建築羣。
市建局於項目試行「浮動規劃參數安排」,在總樓面面積不變下,容許中標發展商靈活調撥指定範圍內商業樓面作辦公室、酒店和其他商業用途,商場樓面不少於約70萬平方尺。市場對項目估值差異較大,介乎約90億元至260億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.